Video Player is loading.
0/12212
2
3
4
5
7
14
37
43
44
48
73
80
81
84
98
105
115
118
120
135
136
137
138
139
140
141
199
1,113
views •
January 12, 2022
Government Control Led to Lack of COVID-19 Remedy: CEO
NTD News
0 Followed
We look at a COVID-19 remedy called monoclonal antibodies—or MAB for short. They are basically antibodies made in a lab and they can potentially be life-saving. But this treatment is in short supply in many areas in the U.S. including but not limited to Connecticut, Nevada, and Ohio. NTD spoke with CEO Michael Einhorn who runs DealMed. He says there are a lot of reasons for the shortage of MABs, but he says government intervention is a main driver.
Show All
Comment 0